|
1
|
Jeebun N, Agnihotri S, Manraj SS and
Purwar B: Study of cervical cancers in mauritius over a twelve
years period (1989–2000) and role of cervical screening. Internet J
Oncol. 3:22005.
|
|
2
|
Morris BJ and Nightingale B: A method of
detection of carcinogenic human papillomavirus. US Patent:
6,218,104 B1. Filed December 30, 1997; issued April 17. 2001
|
|
3
|
Yasuda S, Kojima A, Maeno Y, Oki N,
Miyahara Y, Sudo T, Takekida S, Yamaguchi S and Nishimura R: Poor
prognosis of patients with stage Ib1 adenosquamous cell carcinoma
of the uterine cervix with pelvic lymphnode metastasis. Kobe J Med
Sci. 52:9–15. 2006.PubMed/NCBI
|
|
4
|
Dankert-Roelse JE and te Meerman GJ: Long
term prognosis of patients with cystic fibrosis in relation to
early detection by neonatal screening and treatment in a cystic
fibrosis centre. Thorax. 50:712–718. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang SQ, Yu H and Zhang LL: Clinical
implications of increased lymph vessel density in the lymphatic
metastasis of early-stage invasive cervical carcinoma: A clinical
immunohistochemical method study. BMC Cancer. 9:642009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eades G, Yao Y, Yang M, Zhang Y, Chumsri S
and Zhou Q: miR-200a regulates SIRT1 expression and epithelial to
mesenchymal transition (emt)-like transformation in mammary
epithelial cells. J Biol Chem. 286:25992–26002. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park J and Schwarzbauer JE: Mammary
epithelial cell interactions with fibronectin stimulate
epithelial-mesenchymal transition. Oncogene. 33:1649–1657. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McConkey DJ and Bondar V: Regulation and
function of detachment-induced cell death (Anoikis) in cancer
progression and metastasis. Cancer Drug Discovery and Development:
Apoptosis, Senescence, and Cancer. Gewirtz DA, Holt SE and Grant S:
Humana Press, Inc.; Totowa, NJ: pp. 109–122. 2007, View Article : Google Scholar
|
|
9
|
Venetsanakos E, Mirza A, Fanton C, Romanov
SR, Tlsty T and Mcmahon M: Induction of tubulogenesis in
telomerase-immortalized human microvascular endothelial cells by
glioblastoma cells. Exp Cell Res. 273:21–33. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim YN, Koo KH, Sung JY, Yun UJ and Kim H:
Anoikis resistance: An essential prerequisite for tumor metastasis.
Int J Cell Biol. 2012:3068792012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Middlemas DS, Lindberg RA and Hunter T:
trkB, a neural receptor protein-tyrosine kinase: Evidence for a
full-length and two truncated receptors. Mol Cell Biol. 11:143–153.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schneider R and Schweiger M: A novel
modular mosaic of cell adhesion motifs in the extracellular domains
of the neurogenic trk and trkB tyrosine kinase receptors. Oncogene.
6:1807–1811. 1991.PubMed/NCBI
|
|
13
|
Strohmaier C, Carter BD, Urfer R, Barde YA
and Dechant G: A splice variant of the neurotrophin receptor trkB
with increased specificity for brain-derived neurotrophic factor.
EMBO J. 15:3332–3337. 1996.PubMed/NCBI
|
|
14
|
Wang P, Meng X, Huang Y, Lv Z, Liu J, Wang
G, Meng W, Xue S, Zhang Q, Zhang P and Chen G: MicroRNA-497
inhibits thyroid cancer tumor growth and invasion by suppressing
BDNF. Oncotarget. 8:2825–2834. 2017.PubMed/NCBI
|
|
15
|
Yu Y, Zhang S, Wang X, Yang Z and Ou G:
Overexpression of TrkB promotes the progression of colon cancer.
APMIS. 118:188–195. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan Y, Ye HQ and Ren QC: Upregulation of
the BDNF/TrKB pathway promotes epithelial-mesenchymal transition,
as well as the migration and invasion of cervical cancer. Int J
Oncol. 52:461–472. 2018.PubMed/NCBI
|
|
17
|
Xing ZS, Bai ZM, Liu ZX and Chong Z:
AB038. High tropomyosin related kinase (TrkB) expression induces
epithelial-mesenchymal transition, anoikis resistance and
metastasis in prostatic cancer cells. Transl Androl Urol. 5 (Suppl
1):AB0382016. View Article : Google Scholar :
|
|
18
|
Bao W, Qiu H, Yang T, Luo X, Zhang H and
Wan X: Upregulation of trkb promotes epithelial-mesenchymal
transition and anoikis resistance in endometrial carcinoma. PLoS
One. 8:e706162013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qi D, Ouyang C, Wang Y, Zhang S, Ma X,
Song Y, Yu H, Tang J, Fu W, Sheng L, et al: HO-1 attenuates
hippocampal neurons injury via the activation of BDNF-TrkB-PI3K/Akt
signaling pathway in stroke. Brain Res. 1577:69–76. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yao RQ, Qi DS, Yu HL, Liu J, Yang LH and
Wu XX: Quercetin attenuates cell apoptosis in focal cerebral
ischemia rat brain via activation of BDNF-TrkB-PI3K/Akt signaling
pathway. Neurochem Res. 37:2777–2786. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Germanà A, Sánchez-Ramos C, Guerrera MC,
Calavia MG, Navarro M, Zichichi R, García-Suárez O, Pérez-Piñera P
and Vega JA: Expression and cell localization of brain-derived
neurotrophic factor and TrkB during zebrafish retinal development.
J Anat. 217:214–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Odate S, Nakamura K, Onishi H, Kojima M,
Uchiyama A, Nakano K, Kato M, Tanaka M and Katano M: TrkB/BDNF
signaling pathway is a potential therapeutic target for pulmonary
large cell neuroendocrine carcinoma. Lung Cancer. 79:205–214. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Creasman W: Revised FIGO staging for
carcinoma of the endometrium. Int J Gynaecol Obstet. 105:1092009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen B, Liang Y, He Z, An Y, Zhao W and Wu
J: Autocrine activity of BDNF induced by the STAT3 signaling
pathway causes prolonged TrkB activation and promotes human
non-small-cell lung cancer proliferation. Sci Rep. 6:304042016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Au CW, Siu MX, Liao X, Wong ES, Ngan HY,
Tam KF, Chan DC, Chan QK and Cheung AN: Tyrosine kinase B receptor
and BDNF expression in ovarian cancers-Effect on cell migration,
angiogenesis and clinical outcome. Cancer Lett. 281:151–161. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo D, Hou X, Zhang H, Sun W, Zhu L, Liang
J and Jiang X: More expressions of BDNF and TrkB in multiple
hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis,
supressed invasion of HepG2 and HCCLM3 cells. J Exp Clin Cancer
Res. 30:972011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Minichiello L, Casagranda F, Tatche RS,
Stucky CL, Postigo A, Lewin GR, Davies AM and Klein R: Point
mutation in trkB causes loss of NT4-dependent neurons without major
effects on diverse BDNF responses. Neuron. 21:335–345. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Douma S, Van Laar T, Zevenhoven J,
Meuwissen R, Van Garderen E and Peeper DS: Suppression of anoikis
and induction of metastasis by the neurotrophic receptor TrkB.
Nature. 430:1034–1039. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang ZF, Ho DW, Lau CK, Tam KH, Lam CT,
Poon RT and Fan ST: Platelet activation during tumor development,
the potential role of BDNF-TrkB autocrine loop. Biochem Biophys Res
Commun. 346:981–985. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Okugawa Y, Tanaka K, Inoue Y, Kawamura M,
Kawamoto A, Hiro J, Saigusa S, Toiyama Y, Ohi M, Uchida K, et al:
Brain-derived neurotrophic factor/tropomyosin-related kinase B
pathway in gastric cancer. Br J Cancer. 108:121–130. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Okamura K, Harada T, Wang S, Ijichi K,
Furuyama K, Koga T, Okamoto T, Takayama K, Yano T and Nakanishi Y:
Expression of TrkB and BDNF is associated with poor prognosis in
non-small cell lung cancer. Lung Cancer. 78:100–106. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vanhecke E, Adriaenssens E, Verbeke S,
Meignan S, Germain E, Berteaux N, Nurcombe V, Le Bourhis X and
Hondermarck H: Brain-derived neurotrophic factor and
neurotrophin-4/5 are expressed in breast cancer and can be targeted
to inhibit tumor cell survival. Clin Cancer Res. 17:1741–1752.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ng YK, Wong EY, Lau CP, Chan JP, Wong SC,
Chan AS, Kwan MP, Tsao SW, Tsang CM, Lai PB, et al: K252a induces
anoikis-sensitization with suppression of cellular migration in
Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma cells.
Invest New Drugs. 30:48–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pearse RN, Swendeman SL, Li Y, Rafii D and
Hempstead BL: A neurotrophin axis in myeloma: TrkB and BDNF promote
tumor-cell survival. Blood. 105:4429–4436. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Geiger TR and Peeper DS: Critical role for
TrkB kinase function in anoikis suppression, tumorigenesis, and
metastasis. Cancer Res. 67:6221–6229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sandhya VK, Raju R, Verma R, Advani J,
Sharma R, Radhakrishnan A, Nanjappa V, Narayana J, Somani BL,
Mukherjee KK, et al: A network map of BDNF/TRKB and BDNF/p75NTR
signaling system. J Cell Commun Signal. 7:301–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen JS, Wang Q, Fu XH, Huang XH, Chen XL,
Cao LQ, Chen LZ, Tan HX, Li W, Bi J and Zhang LJ: Involvement of
PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in
hepatocellular carcinoma: Association with MMP-9. Hepatol Res.
39:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nakashio A, Fujita N and Tsuruo T:
Topotecan inhibits VEGF- and bFGF-induced vascular endothelial cell
migration via downregulation of the PI3K-Akt signaling pathway. Int
J Cancer. 98:36–41. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nozhat Z and Hedayati M: PI3K/AKT pathway
and its mediators in thyroid carcinomas. Mol Diagn Ther. 20:13–26.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xia H, Li Y and Lv X: MicroRNA-107
inhibits tumor growth and metastasis by targeting the BDNF-mediated
PI3K/AKT pathway in human non-small lung cancer. Int J Oncol.
49:1325–1333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kallergi G, Agelaki S, Kalykaki A,
Stournaras C, Mavroudis D and Georgoulias V: Phosphorylated EGFR
and PI3K/Akt signaling kinases are expressed in circulating tumor
cells of breast cancer patients. Breast Cancer Res. 10:R802008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cheng PL, Song AH, Wong YH, Wang S, Zhang
X and Poo MM: Self-amplifying autocrine actions of BDNF in axon
development. Proc Natl Acad Sci USA. 108:18430–18435. 2011.
View Article : Google Scholar : PubMed/NCBI
|
